Mint Tower Capital Management’s Cidara Therapeutics CDTX Stock Holding History

Mint Tower Capital Management’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,000	Closed	-$1.1M	–	339
2025 Q4	$1.1M	Buy	+5,000	New	+$808K	0.13%	126

Mint Tower Capital Management's CDTX Position: Q1 2026 in Review

Mint Tower Capital Management sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 5,000 shares — an estimated $1.1M sold.

Mint Tower Capital Management first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $1.1M in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Mint Tower Capital Management reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Mint Tower Capital Management sold 5,000 Cidara Therapeutics shares in Q1 2026, an estimated $1.1M.
Mint Tower Capital Management first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Mint Tower Capital Management's Cidara Therapeutics position peaked at $1.1M in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Mint Tower Capital Management's 13F filing for Q1 2026, filed 4 May 2026.